journal article·2019-06Open access

Two‐dimensional graphene oxide‐reinforced porous biodegradable polymeric nanocomposites for bone tissue engineering

Behzad Farshid, Gaurav Lalwani, Meisam Shir Mohammadi, Jeyantt Srinivas Sankaran, Sunny Patel, Stefan Judex, John Simonsen, Balaji Sitharaman

Abstract

Abstract This study investigates the mechanical properties and in vitro cytotoxicity of two‐dimensional (2D) graphene oxide nanoribbons and nanoplatelets (GONRs and GONPs) reinforced porous polymeric nanocomposites. Highly porous poly(propylene fumarate) (PPF) nanocomposites were prepared by dispersing 0.2 wt % single‐ and multiwalled SONRs (SWGONRs and MWGONRs) and GONPs. The mechanical properties of scaffolds were characterized using compression testing and in vitro cytocompatibility was assessed using QuantiFlour assay for cellularity and PrestoBlue assay for cell viability. Immunofluorescence was used to assess collagen‐I expression and deposition in the extracellular matrix. Porous PPF scaffolds were used as a baseline control and porous single and multiwalled carbon nanotubes (SWCNTs and MWCNTs) reinforced nanocomposites were used as positive controls. Results show that incorporation of 2D graphene nanomaterials leads to an increase in the mechanical properties of porous PPF nanocomposites with following the trend: MWGONRs > GONPs > SWGONRs > MWCNTs > SWCNTs > PPF control. MWGONRs showed the best enhancement of compressive mechanical properties with increases of up to 26% in compressive modulus (i.e., Young's modulus), ~60% in yield strength, and ~24% in the ultimate compressive strength. Addition of 2D nanomaterials did not alter the cytocompatibility of porous PPF nanocomposites. Furthermore, PPF nanocomposites reinforced with SWGONRs, MWGONRs, and GONPs show an improvement in the adsorption of collagen‐I compared to PPF baseline control. The results of this study show that 2D graphene nanomaterial reinforced porous PPF nanocomposites possess superior mechanical properties, cytocompatibility, and increased protein adsorption. The favorable cytocompatibility results opens avenues for in vivo safety and efficacy studies for bone tissue engineering applications. © 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 1143–1153, 2019.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Graphene and Nanomaterials Applications · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering Stony Brook University Stony Brook New York 11794

Department of Materials Science and Engineering Stony Brook University Stony Brook New York 11794

Department of Wood Science and Engineering Oregon State University Corvallis Oregon 97331

Department of Mechanical, Industrial and Manufacturing Engineering Oregon State University Corvallis Oregon 97331

Funding

U.S. Department of Energy · National Institutes of Health

References (63)

Show source-provided references
1. 10.1097/PRS.0b013e3181cb63a310.1097/PRS.0b013e3181cb63a3 ↗
2. Poser JW · 2017
3. 10.1016/S0142-9612(00)00102-210.1016/S0142-9612(00)00102-2 ↗
4. 10.3928/0147-7447-20020502-0410.3928/0147-7447-20020502-04 ↗
5. 10.1002/9781118574775.ch1010.1002/9781118574775.ch10 ↗
6. 10.1142/9789814401449_000410.1142/9789814401449_0004 ↗
7. Ning C · 2016 · 35
8. 10.1016/S1369-7021(08)70086-510.1016/S1369-7021(08)70086-5 ↗
9. 10.1201/978131536353010.1201/9781315363530 ↗
10. 10.1039/9781788010542-0016910.1039/9781788010542-00169 ↗
11. 10.1016/B978-1-78242-452-9.00002-910.1016/B978-1-78242-452-9.00002-9 ↗
12. 10.1016/S0142-9612(00)00106-X10.1016/S0142-9612(00)00106-X ↗
13. Shi X · 2006
14. 10.1080/09205063.2017.128618410.1080/09205063.2017.1286184 ↗
15. 10.1021/acsbiomaterials.6b0002610.1021/acsbiomaterials.6b00026 ↗
16. 10.1021/jacs.7b0997810.1021/jacs.7b09978 ↗
17. 10.1016/j.actbio.2014.12.02410.1016/j.actbio.2014.12.024 ↗
18. Luo Wade ME WalkerJ LarsenM MonteloneS SwanB MartinK SkorackiR LarsenP EmamH KleinfehnA.2017 December. Craniomaxillofacial tissue regeneration using 3D‐printed poly (propylene fumarate) tissue engineered bone grafts. In Tissue Engineering Part A (Vol. 23 pp. S97‐S97). 140 Huguenot street New Rochelle NY 10801 USA: Mary Ann Liebert Inc.
19. 10.1021/acs.biomac.7b0014610.1021/acs.biomac.7b00146 ↗
20. 10.1016/j.biomaterials.2007.05.03310.1016/j.biomaterials.2007.05.033 ↗
21. 10.1002/jbm.a.3167110.1002/jbm.a.31671 ↗
22. 10.1163/15685620778103413310.1163/156856207781034133 ↗
23. 10.1016/j.bone.2008.04.01310.1016/j.bone.2008.04.013 ↗
24. 10.1002/jbm.b.3356510.1002/jbm.b.33565 ↗
25. 10.1002/jbm.a.3536310.1002/jbm.a.35363 ↗
26. 10.1021/bm301995s10.1021/bm301995s ↗
27. 10.1016/j.actbio.2013.05.01810.1016/j.actbio.2013.05.018 ↗
28. 10.1016/j.biomaterials.2006.01.03910.1016/j.biomaterials.2006.01.039 ↗
29. 10.1038/nature0787210.1038/nature07872 ↗
30. ChenT ZengB LiuJL DongJH LiuXQ WuZ YangXZ LiZM 2009. High throughput exfoliation of graphene oxide from expanded graphite with assistance of strong oxidant in modified Hummers method. J Phys Conf Ser: Conference Series (Vol. 188 No. 1 p. 012051). IOP Publishing.10.1088/1742-6596/188/1/012051 ↗
31. 10.1038/nprot.2009.2410.1038/nprot.2009.24 ↗
32. 10.1002/ppsc.20130031810.1002/ppsc.201300318 ↗
33. 10.1039/C4TB00976B10.1039/C4TB00976B ↗
34. 10.1038/srep1026110.1038/srep10261 ↗
35. Standard A. D695–02a · 2002
36. Raman spectroscopy of graphene and related materials
37. 10.1016/j.carbon.2008.02.01210.1016/j.carbon.2008.02.012 ↗
38. 10.1016/j.compositesa.2015.06.00210.1016/j.compositesa.2015.06.002 ↗
39. 10.1007/s10853-016-0143-x10.1007/s10853-016-0143-x ↗
40. Shir MohammadiM. Developing Design Model for Cellulose Nanocomposites (Doctoral dissertation Oregon State University)2016.
41. 10.1021/nn101781v10.1021/nn101781v ↗
42. 10.1007/s12034-008-0032-210.1007/s12034-008-0032-2 ↗
43. 10.1002/jbm.a.3606210.1002/jbm.a.36062 ↗
44. 10.1002/jbm.a.3586710.1002/jbm.a.35867 ↗
45. 10.1007/s10439-016-1623-510.1007/s10439-016-1623-5 ↗
46. 10.1007/978-1-59745-198-7_310.1007/978-1-59745-198-7_3 ↗
47. 10.1021/bm030015010.1021/bm0300150 ↗
48. 10.1117/1.314740710.1117/1.3147407 ↗
49. 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H ↗
50. 10.1089/10763270130000326910.1089/107632701300003269 ↗
51. 10.1088/1748-6041/6/5/05501010.1088/1748-6041/6/5/055010 ↗
52. 10.1002/cplu.20120001210.1002/cplu.201200012 ↗
53. 10.1002/jbm.a.3544910.1002/jbm.a.35449 ↗
54. 10.1074/jbc.M20854420010.1074/jbc.M208544200 ↗
55. 10.1088/0957-4484/16/7/03010.1088/0957-4484/16/7/030 ↗
56. 10.1016/j.addr.2016.04.02810.1016/j.addr.2016.04.028 ↗
57. 10.1016/j.biomaterials.2014.02.05410.1016/j.biomaterials.2014.02.054 ↗
58. Physicochemical characterization of a novel graphene‐based magnetic resonance imaging contrast agent
59. 10.1016/j.pacs.2013.10.00110.1016/j.pacs.2013.10.001 ↗
60. 10.1039/C4TB00326H10.1039/C4TB00326H ↗
61. 10.4155/tde.15.9310.4155/tde.15.93 ↗
62. 10.1039/C6TB03010F10.1039/C6TB03010F ↗
63. 10.1016/j.biomaterials.2012.09.05710.1016/j.biomaterials.2012.09.057 ↗